Spontaneous evolution in chronic hepatitis C of ALT and HCV viremia in untreated patients with no or minimal histological activity.

被引：0
|
作者：
DuclosVallee, JC
Pawlotsky, JM
Taieb, J
LaurentPuig, P
Altman, C
Hagege, H
Castera, L
Dussaix, E
Bedossa, P
Buffet, C
机构：
[1] HEPATOL UNIT,F-94275 LE KREMLIN BICETR,FRANCE
[2] DEPT VIROL,F-94010 CRETEIL,FRANCE
[3] DEPT VIROL,F-94275 LE KREMLIN BICETR,FRANCE
[4] PATHOL UNIT,F-94275 LE KREMLIN BICETR,FRANCE
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1513 / 1513
页数：1
相关论文
共 50 条
  • [21] Relationships between HCV genotypes, viremia and histopathological manifestations in chronic hepatitis C
    Delladetsima, IK
    Daimonakou, M
    Tassopoulos, NC
    Ketikoglou, I
    Tsantoulas, D
    Vafiadis, I
    Hatzis, G
    Akriviadis, E
    Bassiaris, C
    Sypsa, V
    Hatzakis, A
    JOURNAL OF HEPATOLOGY, 2001, 34 : 173 - 173
  • [22] Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients
    Tabone, M
    Ercole, E
    Zaffino, C
    Bruno, FS
    Pera, A
    Bonino, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 30 (06): : 611 - 613
  • [23] Pre, during and post interferon (IFN) patterns of HCV viremia in patients with chronic hepatitis C (CHC).
    Olaso, V
    Cordoba, J
    Prieto, M
    Berenguer, M
    Lainez, B
    Carrasco, D
    Lopez, B
    Gobernado, M
    Berenguer, J
    HEPATOLOGY, 1996, 24 (04) : 142 - 142
  • [24] Seroprevalence and viremia of hepatitis C (HCV) in blood donors and patients with chronic liver disease in Niger.
    Michielsen, PP
    DeGroof, D
    Hassane, A
    Leyssens, N
    Ramon, AM
    HEPATOLOGY, 1997, 26 (04) : 1729 - 1729
  • [25] Histological evaluation on 806 patients with HCV chronic hepatitis (HCV-CH).
    Sagnelli, E
    Pasquale, G
    Scarano, F
    Filippini, P
    Felaco, FM
    Stanzione, M
    Coppola, N
    Rossi, G
    Scolastico, C
    Piccinino, F
    HEPATOLOGY, 1998, 28 (04) : 206A - 206A
  • [26] Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C
    Tanaka, K
    Ikeda, M
    Nozaki, A
    Kato, N
    Tsuda, H
    Saito, S
    Sekihara, H
    LACTOFERRIN: STRUCTURE, FUNCTION AND APPLICATIONS, 2000, 1195 : 361 - 367
  • [27] Importance of Minimal Residual Viremia for Relapse Prediction in Patients With Chronic Hepatitis C Genotype 1 Infection
    Wiegand, Johannes
    Neumann, Konrad
    Boehm, Stephan
    Weich, Viola
    Teuber, Gerlinde
    Klinker, Hartwig
    Moeller, Bernd
    Rasenack, Jens
    Hinrichsen, Holger
    Gerlach, Tilman
    Spengler, Ulrich
    Buggisch, Peter
    Sarrazin, Christoph
    Berg, Thomas
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (11) : 1111 - 1114
  • [28] CORRELATION BETWEEN HEPATITIS-B VIREMIA AND THE CLINICAL AND HISTOLOGICAL ACTIVITY OF CHRONIC DELTA-HEPATITIS
    LOZANO, JL
    CRESPO, J
    DELACRUZ, F
    CASAFONT, F
    LOPEZARIAS, MJ
    MARTINRAMOS, L
    PONSROMERO, F
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1994, 183 (03) : 159 - 167
  • [29] Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C.
    Tanaka, K
    Ikeda, M
    Saito, S
    Numata, K
    Morimoto, M
    Shirato, K
    Yamauchi, K
    Teraguchi, S
    Nozaki, A
    Kato, N
    HEPATOLOGY, 2001, 34 (04) : 424A - 424A
  • [30] The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients
    Bal, Tayibe
    Onlen, Yusuf
    Babayigit, Cenk
    Yumer, Yusuf
    Sahin, Selma Ilkay
    AFRICAN HEALTH SCIENCES, 2019, 19 (02) : 1988 - 1992
12345